This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petraityte, R.
Right arrow Articles by Sasnauskas, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petraityte, R.
Right arrow Articles by Sasnauskas, K.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, December 2007, p. 1603-1608, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00188-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Use of Saccharomyces cerevisiae-Expressed Recombinant Nucleocapsid Protein To Detect Hantaan Virus-Specific Immunoglobulin G (IgG) and IgM in Oral Fluid{triangledown}

Rasa Petraityte,1* Li Jin,2 Rashpal Hunjan,2 Ausra Razanskiene,1 Aurelija Zvirbliene,1 and Kestutis Sasnauskas1

Institute of Biotechnology, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania,1 Virus Reference Division, Centre for Infections, Health Protection Agency, Colindale, London, United Kingdom2

Received 4 May 2007/ Returned for modification 25 July 2007/ Accepted 27 September 2007

Hantaan virus is the causative agent of severe hemorrhagic fever with renal syndrome. Clinical surveillance for Hantaan virus infection is unreliable, and laboratory verification is essential. The detection of virus-specific immunoglobulin M (IgM) and IgG in serum is most commonly used for the diagnosis of hantavirus infection. Testing of oral fluid samples instead of serum offers many advantages for surveillance. However, commercial tests for hantavirus-specific antibodies are unavailable. For the detection of Hantaan virus in the oral fluid of humans, we have developed a monoclonal antibody-based capture enzyme-linked immunosorbent IgM assay (IgM capture ELISA) and indirect enzyme-linked immunosorbent IgG and IgM assays (indirect IgG and IgM ELISAs) for paired serum and oral fluid samples using the Saccharomyces cerevisiae yeast-expressed nucleocapsid protein of the Hantaan-Fojnica virus. The sensitivity and specificity of the oral fluid IgM capture ELISA in comparison with the results of the serum Hantaan virus IgM assay were 96.7% and of 94.9%, respectively. Thus, data on the overall performance of the oral fluid IgM capture ELISA are in close agreement with those of the serum IgM assay, and the method exhibits the potential to serve as an easily transferable tool for large-scale epidemiological studies. Data on the indirect IgM ELISA also showed close agreement with the serum IgM assay data; however, the indirect IgG ELISA displayed a lower sensitivity and a lower specificity. In conclusion, the IgM capture ELISA can be used with oral fluid instead of serum samples for the diagnosis of Hantaan virus infection.

* Corresponding author. Mailing address: Laboratory of Eukaryote Gene Engineering, Institute of Biotechnology, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania. Phone: (370 5) 2602888. Fax: (370 5) 2602116. E-mail: prasa{at}ibt.lt

{triangledown} Published ahead of print on 3 October 2007.

Clinical and Vaccine Immunology, December 2007, p. 1603-1608, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00188-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»